Latest News — Page 10
Clinical Practice
Investing in Future Generations Through the Economics of Health for All
Finland, UNRISD and the WHO asked what the Economics of Health for All strategy means for the next generation, from intergenerational fairness and participatory foresight to dignified access to care. #SyenzaNews #HealthEconomics #WellbeingEconomy
Europe
Drug Reimbursement in France Keeps Rising. So Why Do Patients Feel Shortchanged?
France reimbursed 90% of drug costs in 2024, yet many patients still feel shortchanged. Maurice-Pierre Planel breaks down the numbers behind the paradox. #SyenzaNews #MarketAccess #PharmaPolicy
Cardiovascular And Metabolic Diseases
Specialist Payment Models: Triple the Cardiac Testing, No Difference in Outcomes
In Alberta, patients of fee-for-service heart specialists receive roughly three times the cardiac testing, with no measurable difference in outcomes. #HealthEconomics #PhysicianPayment #SyenzaNews
Clinical Practice
Zepbound Lowers Healthcare Costs in Adults Over 55 Study Shows
A real-world study from Eli Lilly finds sustained Zepbound use lowers healthcare costs in adults over 55, with savings exceeding the Medicare GLP-1 Bridge price within 12 months. #SyenzaNews #MarketAccess #Obesity #HealthEconomics
Clinical Practice
EMA Authorises Ablymico, a Synthetic Liraglutide for Weight Management
EMA has authorised Ablymico, a synthetic liraglutide for weight management. The approval, granted on 15 July 2026, covers adults, adolescents and children from age six. Ablymico is bioequivalent to Saxenda but is produced by chemical synthesis rather than living cells. #SyenzaNews #MarketAccess #Obesity #GLP1
Clinical Practice
FDA Authorizes Abbott’s Libre Duo, First Continuous Glucose Ketone Monitor
The FDA has cleared Abbott’s Libre Duo 10 Day, the first continuous glucose ketone monitor that tracks ketones and glucose every minute to flag diabetic ketoacidosis risk before it becomes an emergency. #SyenzaNews #Diabetes #MedicalDevices #MarketAccess
Health Equity And Access To Care
Health Department: Local Pharma’s Woes Are Regulatory, Not a Failure of Procurement
South Africa’s health department pushes back on claims that state tenders are hollowing out pharmaceutical manufacturing, arguing the sector’s real pressures are regulatory rather than the result of procurement decisions.
Europe
HTAi 2026 Annual Meeting: HTA Moves From Evaluation to System Shaping
The HTAi 2026 Annual Meeting in Istanbul drew 780+ delegates from 64 countries to reframe HTA as a system shaper, not just an evaluator of technologies.
Big Data Analysis
EMA and HMA Open Consultation on the EMRN Data Standards Framework
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have opened a public consultation on a draft EMRN data standards framework, the governance document that will shape how the European medicines regulatory network adopts, creates, updates, and implements data standards for human and veterinary medicines. The draft, published under reference EMA/185661/2026 and dated 1 July 2026, is open for comment from 17 August to 18 September 2026. Responses go through an EUSurvey form linked in the consultation […]
Clinical Practice
Hanmi Genentech Licensing Deal for Obesity Drug HM17321
Hanmi Pharm has signed a licensing deal with Genentech for its novel obesity candidate HM17321, worth up to $2.3 billion. The UCN2 analog is designed to cut weight while preserving lean muscle mass, a gap GLP-1 therapies have not filled. #SyenzaNews #biotechnology #drugdevelopment #MarketAccess
Artificial Intelligence And Machine Learning
A Multi-Agent Clinical Trials Framework to Automate Trial Center Operations
Weill Cornell researchers have proposed ASTRA, a multi-agent system that would delegate routine clinical trial work to AI agents while human experts keep the final say on clinical and regulatory decisions.
Clinical Practice
Trodelvy First-Line Approval Expands Metastatic TNBC Options
The European Commission has approved Trodelvy plus Keytruda for first-line metastatic triple-negative breast cancer, making Trodelvy the first ADC-based backbone across PD-L1 status.
Clinical Guidelines And Protocols
New DISH Surgical Classification System Standardises Wound Outcome Reporting
A new consensus framework grades dehiscence, infection, seroma, and haematoma in a single score, with strong agreement across 60 specialists.
Cannabidiol
Portugal Medicinal Cannabis Exports Reach 83% of 2025 Total in Six Months
Portugal medicinal cannabis exports reached 66,305 kg in the first half of 2026, according to INFARMED, already 83% of the 79,883 kg shipped across all of 2025. The country’s medicines regulator published the figures in its mid-year report on the sector, which also shows cultivation and manufacturing licences easing back after several years of rapid expansion. Portugal began regulating medicinal cannabis in 2018, when the Assembly of the Republic approved a law covering marketing authorisations, prescribing and pharmacy dispensing. A […]
Biologics And Biosimilars
Patients’ Association Asks Portugal’s Ombudsman to Speed Up Generic Medicine Access
💊 Can generic medicines deliver €300 million in savings for Portugal?
Portugal is targeting major cost reductions in its healthcare system by accelerating the uptake of generic medicines, aiming to improve affordability and sustainability. This move highlights strategic efforts in market access and cost-effectiveness within the pharmaceutical sector.
Read the full analysis to see what it means for stakeholders.
#SyenzaNews #pharmaceuticals #MarketAccess #costeffectiveness
Clinical Practice
First Individualized Neoantigen Therapy Meets Phase 3 Endpoints in Melanoma
Merck and Moderna’s individualized neoantigen therapy intismeran has cleared its first Phase 3, beating KEYTRUDA alone in resected high-risk melanoma. The open question now is how payers value a medicine made for one patient at a time.